Introduction
Septa’s Pharma division focuses on Manufacturing, Research and Development and Distribution of high quality of prescription products. Our primary focus is specialty and generic pharmaceutical products for the regulated Canadian markets
Products:
Our Pharmaceuticals arm develops, registers and supplies pharmaceutical products globally. Our primary area of focus is providing cost effective pharmaceutical products in Canada and across the globe. With over 25+ submissions, and numerous products in the Canadian market and globally, we are one of the few fully licensed, Health Canada approved pharmaceutical companies that has a strong and successful history of regulatory compliance and product quality. We partner with global pharmaceutical manufacturers, product development companies, research organizations and scientists to bring cost effective pharmaceutical products to patients.
We are proudly Canadian owned and privately held and pride ourselves in our ‘patient-first’ and ‘pharmacy-friendly’ approach and outlook. We stand behind the integrity and quality of all the products that we supply and have a strong local focus to support patients and pharmacists in an ever-changing regulatory environment.
Within Canada, our products are available coast to coast with major wholesalers, retailers, pharmacy chains, banner pharmacies, pharmacy buying groups and independent pharmacies. All our products are interchangeable, reimbursable by public programs and registered with all provincial formularies, private payers and insurance companies in Ontario, Quebec, Manitoba, Saskatchewan, Alberta, British Columbia and Atlantic Canada.
| PRODUCT NAME | STRENGTH | SCHEDULE |
|---|---|---|
|
Amlodipine |
2.5 mg, 5 mg, 10 mg |
Prescription |
|
Atenolol |
25 mg, 50 mg, 100 mg |
Prescription |
|
Candesartan |
16 mg, 32 mg |
Prescription |
|
Candesartan HCTZ |
32 mg / 12.5 mg, 32 mg / 25 mg |
Prescription |
|
Ciprofloxacin |
250 mg, 500 mg, 750 mg |
Prescription |
|
Citalopram |
10 mg, 20 mg, 40 mg |
Prescription |
|
Donepezil |
5 mg, 10 mg |
Prescription |
|
Losartan |
25 mg, 50 mg, 100 mg |
Prescription |
|
Losartan HCTZ |
50 mg / 12.5 mg , 100 mg / 25 mg |
Prescription |
|
Metformin |
500 mg, 850 mg |
Prescription |
|
Ondansetron |
4 mg, 8 mg |
Prescription |
|
Simvastatin |
5 mg, 10 mg, 20 mg, 40 mg, 80 mg |
Prescription |
|
Telmisartan |
40 mg, 80 mg |
Prescription |
|
Zolmitriptan – ODT |
2.5 mg |
Prescription |
|
Zopiclone |
5 mg, 7.5 mg |
Prescription |
We are constantly adding new products to our portfolio and looking for opportunities to collaborate with Innovators, Product & Formulation Development Organizations, Contract Development Organizations (CDO), Contract Manufacturing Organizations (CMO) and Contract Research Organizations (CRO). If you are looking to collaborate with us or searching for a new partner in Canada, please get in touch with our business development team.
Our near-term product focus area is as follows:
1. Branded Generics
2. Biologics, Biosimilars and Biopharmaceuticals
3. Injectables
4. Vaccines
5. Orphan Drugs and Rare Diseases
If you are a healthcare provider and looking for more information about our products, please contact us for more information.
Shortages:
In a landscape where access to essential medications can fluctuate, we stand as a beacon of reliability and support for healthcare providers and patients alike. With our unwavering commitment to quality and safety, we diligently navigate the complexities of the pharmaceutical supply chain to ensure a consistent availability of vital medications, even during times of scarcity.
Backed by years of expertise and a robust network of 200+ pharmaceutical manufacturers and sourcing partners around the globe, we strive to bridge the gap between demand and availability, empowering healthcare professionals to deliver optimal care to those in need. We understand the urgency of the situation and we are dedicated to providing timely solutions to alleviate the impact of drug shortages on Canadian communities.
Services:
We have deep expertise in Pharmaceutical Formulation Development, Bioequivalence & Bioavailability and Phased Clinical Trials. We support pharmaceutical development and manufacturing companies to successfully commercialize products in Canada and across the world. We work with pharmaceutical, biosimilar, injectable development and manufacturing companies enter the Canadian Market to register, commercialize, market, sell and warehouse products. Our local presence and deep expertise in marketing can provide a turn-key advantage to accelerate product launches with end-to-end expertise in regulatory affairs, quality assurance and supply chain.
Below are just a few of the areas that we can help you get ahead of the competition especially for ‘first to file’ and ‘first to launch’ Pharmaceutical products.
1. Market Analysis, Competition analysis and Customer segmentation with business and financial case preparation
2. Company Registrations, Drug profile setup, dossier i.e. NDS and ANDS submissions
3. Price setting and provincial formulary setup
4. Wholesaler Setup
5. 3PL services for end-to-end supply chain for both ambient and cold-chain products
6. Adverse Reaction, Product Recall and Pharmacovigilance Maintenance
Get in touch with us at info@septapharma.com if you are targeting Canada as a potential market or are looking to enter regulated or semi-regulated markets or to register products in North America, ASEAN, MENA and EU.
Critical Canadian Shortage of Aminophylline Inj. and Carbamazepine XR 200 mg & 400 mg Tabs.
Health Canada has approved Septa Pharma for Exceptional Importation and Supply to mitigate critical Tier 3 shortages.
For inquiries, email us at orders@septapharma.com
For more information, please click here